Differentiation of clear from non-clear cell renal cell carcinoma using CT washout formula

被引:0
|
作者
Kopp, Ryan P. [1 ,2 ]
Aganovic, Lejla [3 ,4 ]
Palazzi, Kerrin L. [1 ]
Cassidy, Fiona H. [3 ,4 ]
Sakamoto, Kyoko [1 ,2 ]
Derweesh, Ithaar H. [1 ,2 ]
机构
[1] Univ Calif San Diego, Sch Med, Dept Surg, Div Urol, La Jolla, CA 92093 USA
[2] San Diego Vet Adm Med Ctr, Surg Serv, La Jolla, CA USA
[3] Univ Calif San Diego, Sch Med, Dept Radiol, La Jolla, CA 92093 USA
[4] San Diego Vet Adm Med Ctr, Serv Radiol, La Jolla, CA USA
关键词
carcinoma; renal cell; computerized tomography; diagnosis; enhancement; histology; Hounsfield unit; PATHOLOGICAL FEATURES; CORTICAL TUMORS; CORE BIOPSY; MASSES; SUNITINIB; PAPILLARY; EFFICACY; CM;
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Introduction: To further elucidate potential patterns of contrast enhancement for renal neoplasm subtypes, we investigated utility of contrast washout formula to differentiate renal tumor histology after multiphase computerized tomography (CT). Materials and methods: Single center retrospective cohort study of 163 patients with multiphase CT for renal masses obtained October 2007 to July 2012. Pathology confirmed clear cell (CC-RCC; n = 92), papillary (Pa-RCC; n = 43), chromophobe (Ch-RCC; n = 6), oncocytoma (OC; n = 11), or angiomyolipoma (AML; n = 11) histology. Two radiologists in consensus and blinded to histology recorded tumor size, morphology, and attenuation measurements in Hounsfield Units (HU). Data were analyzed between subgroups based on histology. Enhancement washout of the tumor was calculated by the formula (Mass nephrographic HU-Mass delayed HU)/(Mass nephrographic HU-Mass non-contrast HU) and used to calculate sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV). Results: Tumor size was largest among CC-RCC (p < 0.001). Homogeneous composition was more common among Pa-RCC and Ch-RCC (p < 0.001). Median washout for Ch-RCC (0.27) was significantly different from that of OC (0.54, p = 0.05). Overall 25 (15.3%) of tumors had washout < 0. Tumors with washout value < 0 were Pa-RCC 24/43 (56%), and Ch-RCC 1/6 (14%). Washout value < 0 had a specificity of 99.2% for Pa-RCC and 100% for non-CC-RCC. Washout value >= 0 had a sensitivity and NPV of 100% for CC-RCC, OC, and AML. Washout value 0 had a specificity of 35.2% and a PPV of 66.7% for CC-RCC. Conclusions: Enhancement washout value < 0 is highly specific for Pa-RCC and non-CC-RCC. Washout value 0 is highly sensitive for CC-RCC, OC, and AML while there was a significant difference in median washout between OC and Ch-RCC. Further prospective investigation is requisite to confirm these findings.
引用
收藏
页码:6790 / 6797
页数:8
相关论文
共 50 条
  • [21] Does immunoscore have a significant effect on survival for non-clear cell renal cell carcinoma as well as clear cell renal cell carcinoma?
    Ismail Selvi
    Umut Demirci
    Nazan Bozdogan
    Halil Basar
    International Urology and Nephrology, 2021, 53 : 1135 - 1138
  • [22] Characterizing Tumor Thrombus Arising from Non-Clear Cell Renal Cell Carcinoma
    Rabinowitz, Matthew J.
    Esfandiary, Tina
    Cheaib, Joseph
    Patel, Sunil H.
    Alam, Ridwan
    Metcalf, Meredith
    Enikeev, Dmitry
    Pierorazio, Phillip M.
    Ged, Yasser M. A.
    Allaf, Mohamad E.
    Singla, Nirmish
    EUROPEAN UROLOGY OPEN SCIENCE, 2022, 43 : 28 - 34
  • [23] Identification of novel biomarkers to distinguish clear cell and non-clear cell renal cell carcinoma using bioinformatics and machine learning
    Panwoon, Chanita
    Seubwai, Wunchana
    Thanee, Malinee
    Sangkhamanon, Sakkarn
    PLOS ONE, 2024, 19 (06):
  • [24] Does immunoscore have a significant effect on survival for non-clear cell renal cell carcinoma as well as clear cell renal cell carcinoma?
    Selvi, Ismail
    Demirci, Umut
    Bozdogan, Nazan
    Basar, Halil
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2021, 53 (06) : 1135 - 1138
  • [25] Differentiation of clear cell and non-clear cell renal cell carcinomas by all-relevant radiomics features from multiphase CT: a VHL mutation perspective
    Zhi-Cheng Li
    Guangtao Zhai
    Jinheng Zhang
    Zhongqiu Wang
    Guiqin Liu
    Guang-yu Wu
    Dong Liang
    Hairong Zheng
    European Radiology, 2019, 29 : 3996 - 4007
  • [26] Differentiation of clear cell and non-clear cell renal cell carcinomas by all-relevant radiomics features from multiphase CT: a VHL mutation perspective
    Li, Zhi-Cheng
    Zhai, Guangtao
    Zhang, Jinheng
    Wang, Zhongqiu
    Liu, Guiqin
    Wu, Guang-yu
    Liang, Dong
    Zheng, Hairong
    EUROPEAN RADIOLOGY, 2019, 29 (08) : 3996 - 4007
  • [27] Morphological features and prognosis of non-clear cell renal cell carcinoma types
    Zakharava, V.
    Liatkouskaya, T.
    Kiselev, P.
    Cherstvoy, E.
    Lapec, A.
    VIRCHOWS ARCHIV, 2018, 473 : S335 - S336
  • [28] Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview
    Bergmann, Lothar
    Weber, Sarah
    Hartmann, Arndt
    Ahrens, Marit
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (11) : 1273 - 1286
  • [29] Systematic Review of Treatment of Metastatic Non-Clear Cell Renal Cell Carcinoma
    Brown, Jason R.
    Calaway, Adam
    Castle, Erik
    Garcia, Jorge
    Barata, Pedro C.
    KIDNEY CANCER, 2022, 6 (01) : 53 - 68
  • [30] EFFICACY AND SAFETY OF SUNITINIB IN PATIENTS WITH NON-CLEAR CELL RENAL CELL CARCINOMA
    Lee, J. -L.
    Ahn, J. -H.
    Park, S. H.
    Lim, H. Y.
    Lee, S. H.
    Kim, T. -M.
    Cho, Y. -M.
    Song, C.
    Hong, J. H.
    Kim, C. -S.
    Ahn, H.
    ANNALS OF ONCOLOGY, 2012, 23 : 141 - 141